Patent · US Expired

Human myeloperoxidase and its therapeutic application

US5846799A · kind A · utility

1Cited by

1References

6Claims

0Family size

Assignee

LaRegion Wallone · BE

Inventors

Carol Deby · Liège, BE
Joel Pincemail · Esneux, BE
Alex Bollen · Itterbeek, BE

Key dates

Filing date	Aug 20, 1993
Grant date	Dec 8, 1998
Priority date	—
Expiry date	Aug 20, 2013

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K38/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A method of preparing biologically active human myeloperoxidase including the steps of preparing a vector for the expression of human myeloperoxidase. The vector includes plasmid pNIV2703. The plasmid includes a HindIII-SnaBI, HindIII-EcoRV or HindIII-HpaI cassette, the cassette including a complete DNA sequence for hMPO as shown in FIG. 1. CHO cells are transformed with the vector. The cells are cultured. The biologically active human myeloperoxidase is recovered.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.